Background: This paper presents results from the inaugural Scope of Practice Survey of Optometry Australia members conducted in October 2015. The survey gathered information related to confidence in detecting and diagnosing key ocular conditions, grading diabetic retinopathy, prescribing scheduled medicines, access to equipment, confidence using equipment, incidence of patients requiring therapeutic management, referral practices and services provided. Methods: The survey was developed, piloted, modified and administered to members of Optometry Australia (excluding student and retired members), who had a current email address. Results were collated and analysed using Microsoft Excel. Results: Of the 587 optometrists in clinical practice who responded, 254 (43 per cent) had therapeutic endorsement of registration. The majority of respondents practised in a major city or surrounding suburbs (63 per cent). Independent practice was the most frequently cited practice type (58 per cent). The estimated average number of patients seen in a week was 48; there was a steady decrease in the number of patients per week with increasing age, from 53 for optometrists in their 20s to 27 for optometrists aged over 70. There was very high confidence (over 93 per cent) in ability to grade diabetic retinopathy and diagnose a range of ocular conditions. Confidence in performance of more advanced techniques was higher for endorsed than non-endorsed optometrists. Approximately 12 per cent of patients required a Schedule 4 therapeutic prescription. The most frequently recommended over-the-counter medications were for dry eye for both endorsed and non-endorsed optometrists. The most frequently prescribed Schedule 4 medications were anti-inflammatories. The most challenging conditions to prescribe for were glaucoma, microbial keratitis and uveitis. Approximately one in six therapeutically endorsed optometrists reported unexpected side effects of medications they had prescribed. Conclusion: Information from the survey will guide Optometry Australia in the design of continuing professional development programs and other materials.
The scope of practice of optometrists in Australia is changing with developments in technology and new forms of treatment of a range of conditions that allow interventions that were not previously possible and are necessary because of the growing ocular health needs of an ageing population with longer life expectancy. The scope of practice of optometrists is, in part, determined by their registration status, specifically whether or not they have therapeutic endorsement of their registration to allow them to prescribe scheduled medicines (S4 medications) for the treatment of ocular conditions. 1 This endorsement of registration has only been in place since 2000, when legislation came into effect that allowed optometrists in the state of Victoria with suitable additional training to have therapeutic endorsement. 2 Subsequently, optometrists in all other states have been able to have therapeutic endorsement if they have undertaken the necessary additional training and since 2014, therapeutic training has been incorporated in all entrylevel programs, so that graduates of optometric courses are automatically entitled to therapeutic endorsement when they register as an optometrist.
No detailed data are available to indicate the degree to which the need for a therapeutic prescription is encountered in optometric practice, the number of prescriptions that are generated or the confidence of optometrists in prescribing. In addition, technology has continued to evolve with highly sophisticated equipment now available in some optometric practices but little is known about the use of this equipment, as the only data currently collected relates to service type and ages and gender of patients assessed under the Australia healthcare program, Medicare. 3 The aim of the paper is to present results from the inaugural Scope of Practice Survey on clinical practice of optometrists who are members of Optometry Australia, with a particular emphasis on their confidence in diagnosing, use of equipment, prescribing of scheduled medicines, referral practices and their patient base.
developed the survey to investigate optometric scope of practice of its members. Ethics approval was obtained from the Social and Behavioural Research Ethics Committee, Flinders University (#6974). The investigation was conducted in accordance with the Declaration of Helsinki of 1975.
Following piloting with six Optometry Australia members that resulted in some finetuning of the content, the final version of the survey was administered through PHCRIS in October 2015 via an email link sent to the 3,948 Optometry Australia members for whom an email address was known. (Student and retired members were not included and 63 members had not provided email addresses). Thirty-one emails were undeliverable, resulting in a total of 3,917 optometrists being invited to participate in the survey (97.7 per cent of the membership).
The survey collected data on: 1. demographic information 2. patient diagnosis 3. techniques 4. therapeutic prescribing 5. treatment of patients with glaucoma 6. general practitioner referrals 7. areas of interest and 8. average numbers of patients and prescriptions. Data received from optometrists in clinical practice were entered into Microsoft Excel spreadsheets for analysis.
For responses to questions that were given as falling within a particular range, the midpoint of each range was multiplied by the number of respondents reporting that range. Where an actual value had been supplied this value was multiplied by the frequency with which it was reported. The sum of both sets of products was divided by the number of optometrists answering the question to obtain the average.
RESULTS
While 606 optometrists undertook the survey, 19 were not in clinical practice, resulting in an effective response rate of 15 per cent (587 of 3,898). Of these 587 optometrists, 254 (43 per cent) reported that they were endorsed as qualified to obtain, possess, administer, prescribe or supply Schedule 2, 3 or 4 medicines for the treatment of conditions of the eye (therapeutic endorsement). Schedule 2 -(S2) medicines are pharmacy medicines; Schedule 3 (S3) are pharmacist only medicines; and Schedule 4 (S4) are prescription only medicines. 4 The S4 medications that are permitted are from a list approved by the Optometry Board of Australia (OBA); the list does not include oral medications. 
Demographic information of respondents and number of patients seen
Characteristics of the optometrists in clinical practice responding to the survey are shown in Table 1 Optometrists with therapeutic endorsement tended to have more confidence than optometrists without therapeutic endorsement in the performance of all of the techniques considered in the survey (Figure 1 ). Of the nonendorsed optometrists, a number had not learnt how to perform gonioscopy, pachymetry, optical coherence tomography (OCT), Heidelberg retinal tomography (HRT) or scanning laser polarimetry. Almost all endorsed optometrists could perform the techniques with the exception of scanning laser polarimetry.
Endorsed optometrists were more likely than non-endorsed optometrists to perform the techniques of gonioscopy, pachymetry, OCT/HRT, stereoscopic slitlamp funduscopy, optic disc photography (dilated pupil) and visual fields personally rather than refer on ( Figure 2 ). Over 90 per cent of non-endorsed and 98 per cent of endorsed optometrists personally performed stereoscopic slitlamp funduscopy, optic disc photography (dilated pupil) and visual fields. The majority of non-endorsed optometrists referred for gonioscopy, pachymetry and OCT/HRT (most frequently to an ophthalmologist or an eye hospital), while the majority of endorsed optometrists performed these techniques themselves.
Performance of additional techniques unlikely to be routinely needed in optometric practice is shown in Figure 3 . Very few optometrists perform stromal micro-puncture, blood sugar testing or take scrapes for culturing but most perform epilation and superficial non-corneal foreign body removal.
Recommendation of Schedule 2 and Schedule 3 therapeutic agents for ocular use
Frequencies of recommending S2 and S3 (non-prescription, over-the-counter medications) for ocular use are shown in Table 2 . Endorsed optometrists recommended the products more frequently than did non-endorsed optometrists.
Patients requiring a Schedule 4 therapeutic prescription
On average, optometrists reported seeing six patients per week over the last six months, who required a S4 therapeutic prescription either from the optometrist or through referral elsewhere; if outliers were included ( 
Referral practices for Schedule 4 therapeutic prescriptions NON-ENDORSED OPTOMETRISTS
On average, non-endorsed optometrists referred 53 per cent of patients requiring a S4 therapeutic prescription to an ophthalmologist, 25 per cent to an optometrist who could prescribe S4 medications, 18 per cent to a general medical practitioner and four per cent to a hospital or tertiary facility.
ENDORSED OPTOMETRISTS
Excluding patients requiring management of glaucoma, most referrals by therapeutically 
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Technique by therapeutic endorsement status (Table 3) . Very few therapeutically endorsed optometrists (17 individuals) referred patients for therapeutics because of any single one or a combination of, a lack of confidence or interest, practise policy, time factors or financial reasons (for the optometrist).
Schedule 4 therapeutic prescriptions
Estimates of the numbers of S4 therapeutic prescriptions written show that the most frequently prescribed medications were antiinflammatory medications (Table 4) .
Thirty-four of 214 therapeutically endorsed optometrists reported that in the six months prior to the survey, a patient or patients had experienced unexpected side effects from therapeutic agents the optometrist had prescribed. (The survey did not collect specific data about the type of side effects or actions taken.)
Confidence in prescribing for different conditions
Confidence of therapeutically endorsed optometrists in prescribing for a number of ocular conditions is shown in Figure 4 . Conditions least likely to be independently managed by therapeutically endorsed optometrists were microbial keratitis, uveitis and glaucoma. (Note that the OBA requires optometrists to provide patients with chronic glaucoma a referral to an ophthalmologist or ophthalmological service within four months of commencing treatment. 1 ) *Outliers were respondents where reported values were much higher than the number of patients reported as being seen in a week; the cut-off point for outliers was taken as over 100 scripts) 
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Patients with glaucoma
Many therapeutically endorsed optometrists (157 of 226 or 69.5 per cent) were involved in the treatment of patients with glaucoma. Optometrists who reported that they did not treat patients for glaucoma but always referred, reported that the main external factors preventing them from being involved in the treatment of patients with glaucoma were not having access to equipment, such as OCT, pachymeters or an appropriate visual field analyser, lack of local ophthalmologists offering the option of co-management and difficulties accessing ophthalmological care.
Forty-nine per cent (76 of 155 optometrists) had initiated treatment for patients they had diagnosed with chronic glaucoma. Noting that the OBA requires optometrists to refer all patients for whom they have initiated treatment for glaucoma to an ophthalmologist within four months, the survey also asked optometrists the percentage of patients for whom they had initiated treatment for glaucoma that they considered they could manage without ophthalmological oversight (Table 5 ). In this group of patients, many optometrists reported there were at least some patients whom they considered they could manage without the need for ophthalmological oversight.
Referrals to general medical practitioners and nonophthalmological specialists
Optometrists reported referring patients to general medical practitioners recommending further referral to non-ophthalmological specialists as: never, eight per cent; rarely, 39.6 per cent; occasionally, 46.8 per cent and often, 5.6 per cent. Patients of optometrists referred directly to a specialist other than an ophthalmologist are ineligible for Medicare benefits at the specialist rate, so optometrists are unlikely to refer patients to specialists other than ophthalmologists, even if they feel confident that they know Results for optometrist confidence in referring conditions directly to a specialist other than an ophthalmologist without the need to involve the patient's general practitioner are shown in Table 6 .
Confidence examining and managing different patient groups
Confidence in examining and managing patients in different categories is shown in Table 7 .
Patients with diabetes
Many respondents (92.4 per cent of non-endorsed and 96.4 per cent of endorsed optometrists) reported that they are confident in determining when it is necessary to refer patients with diabetes in accordance with the National Health and Medical Research Council (NHMRC) guidelines. 5 Results regarding recommendation of techniques to patients with diabetes are shown in Table 8 . (The question did not ask the frequency with which the procedures were recommended).
DISCUSSION
Demographic information of respondents and numbers of patients seen
The survey had representation from optometrists in each ten-year age group from 20 to 70 plus, from four practice location regions and a variety of types of practice, as well as from endorsed and non-endorsed optometrists.
The likelihood of therapeutic endorsement decreased with increasing age (both for the data in the current study and for OBA data 6 ). The high proportion in the 20-to 29-year-old group reflects the change for optometric programs in recent years to entitle graduates to therapeutic endorsement, as this is the new entry-level training standard. Optometrists in older age groups would have needed to undertake additional study with associated costs and time away from practice to become endorsed. It might be expected that for some optometrists in the later stages of their career, investment in this study would not be considered a priority, or alternatively that they work within a practice with an endorsed optometrist.
The average number of patients seen per week decreased each decade up to the age group 70 and over. The finding that the youngest group of optometrists saw the highest average number of patients per week may be partly linked to findings reported elsewhere that female optometrists in younger age groups (who are the majority in age groups up to the age of 45) 7 work longer hours than female optometrists in older age groups, although this is not the case with male optometrists. The current study found that the average number of patients seen was higher in corporate practice than in independent practice. There are no publicly available figures indicating average numbers of patients seen by optometrists in Australia; the closest figures can be calculated from Medicare Local reports, which showed that 8.3 million services were provided under Medicare in 2015 by 4,664 providers, which across a 46-week year (accounting for leave, public holidays and sick leave) gives an average of 39 patients per week. 3 This figure, which is lower than the average of 48 found in the current study, does not account for patients for whom services are provided that are either not eligible for a Medicare rebate or where a Medicare rebate has not been claimed.
The estimated average number of patients seen per week was greatest in small rural towns/country areas and least in major cities or surrounding suburbs. This is possibly a consequence of the lower population per optometrist in city areas compared to country areas. In 2014, the Australia Institute of Health and Welfare reported 19.0 full-time equivalent optometrists per 100,000 people in major cities and 10.7 full-time equivalent optometrists per 100,000 people in outer regional and remote areas. 
Patient diagnosis, confidence in performing techniques and referral for techniques
Endorsed optometrists in this sample reported a higher degree of confidence using a number of advanced techniques and technology now available to support the more targeted and detailed diagnosis and management of specific ocular conditions. Examples include techniques such as gonioscopy and pachymetry.
The higher confidence in diagnosis and the performance of advanced techniques of endorsed compared to non-endorsed optometrists is likely to be due, at least in part, to the recency and extent of therapeutic training, whether within the training leading to initial registration that includes therapeutic endorsement or the additional training undertaken for therapeutic endorsement. Courses leading to an optometric qualification undertaken by most respondents under the age of 30 were likely to have incorporated therapeutic training and the use of advanced technology to assist them in the diagnosis and therapeutic management of patient conditions. Older optometrists with therapeutic endorsement would have had access to similar training within their therapeutic qualification. It would be expected that unless they had undertaken advanced courses, non-endorsed optometrists would be less likely than endorsed optometrists to have been trained to perform gonioscopy, pachymetry, OCT/HRT and scanning laser polarimetry. Confidence in performance of these techniques is illustrated by the preference of endorsed optometrists to perform these techniques personally rather than to refer elsewhere to have them performed. These techniques have particular significance in the diagnosis and ongoing management of glaucoma and are important if optometrists are to diagnose and comanage patients with glaucoma with ophthalmologists. 1, 9 It should be noted that equipment, such as that needed for OCT/HRT and scanning laser polarimetry is very expensive and it would not be costeffective for some practitioners to possess the equipment when they could refer patients for these techniques. Similarly, it would be appropriate for an optometrist to refer for pachymetry or gonioscopy as part of the diagnosis of glaucoma, if they did not have the relevant equipment or had it and were unable to use it. Comparison of confidence levels based on endorsement status with previously reported data supports their findings of higher confidence by therapeutically endorsed optometrists compared to non-endorsed optometrists in performing stereoscopic slitlamp funduscopy, pachymetry and gonioscopy. 9 More endorsed than non-endorsed optometrists expressed meibomian glands, removed superficial non-corneal and corneal foreign bodies, undertook Betadine washes, performed corneal debridement and measured blood pressure. Of these techniques, there was a large difference in the proportions removing corneal foreign bodies between the two groups, possibly attributable to the need to prescribe a prophylactic antibacterial medication subsequently or because undergraduate optometric training at the time did not include this technique.
Very few optometrists, whether endorsed or not, performed stromal micro-puncture, scrapes for corneal or conjunctival cultures or blood sugar testing.
Recommendation of Schedule 2 and Schedule 3 therapeutic agents for ocular use
Although both endorsed and non-endorsed optometrists recommended over-thecounter medications, those with therapeutic endorsement were more likely to do so. The most frequent recommendation for both groups is dry eye products, followed by 
Patients requiring a Schedule 4 therapeutic prescription
Of interest is the exposure of optometrists in practice to patients requiring therapeutic management so that expertise can be maintained. On average, six patients per week required this management, representing approximately 12 per cent of the patients seen in a week. There appears to have been an issue with the interpretation of the question, as some optometrists reported more patients requiring a S4 prescription per week than the average number of patients they had reported seeing per week. Data from these optometrists were excluded in the calculation of the mean value of six.
Referral practices for Schedule 4 therapeutic prescriptions
Non-endorsed optometrists were most likely to refer patients requiring a S4 therapeutic medication to an ophthalmologist (53 per cent) or a therapeutically endorsed optometrist (25.3 per cent). This question did not differentiate the types of therapeutic medication required for referrals, which could influence the selection of the most appropriate person for the referral. Very few therapeutically endorsed optometrists referred patients requiring a S4 medication because of lack of time (2.0 per cent), economic reasons (of the optometrist) (2.5 per cent), practice policy (2.4 per cent), lack of interest in therapeutics (1.9 per cent) or lack of confidence in diagnosing/treating/prescribing S4 therapeutics (5.2 per cent). These figures are not additive as some optometrists ticked more than one category. Seventeen therapeutically endorsed optometrists (eight per cent) selected at least one option from these.
Excluding referral for the treatment of glaucoma, the reason for most referrals of patients requiring therapeutic medications by therapeutically endorsed optometrists was when the best medication was an oral medication, reflecting that therapeutically endorsed optometrists are not permitted to prescribe oral medications. The majority of these referrals were to ophthalmologists.
Schedule 4 therapeutic prescriptions
The most frequently prescribed S4 therapeutic medications were anti-inflammatory medications (average of 28.6 scripts in the six months prior to the survey). Only seven per cent of therapeutically endorsed optometrists had not prescribed this medication within this time. Despite the availability of over-the-counter chloramphenicol, optometrists wrote an average of 18 scripts for anti-infective therapeutic medications in the six months prior to the survey, with nine per cent not having written a script for these medications in this period. These prescriptions may indicate a clinical need for a different type of antibiotic rather than chloramphenicol. Some patients requiring anti-infective topical medications may present to their general medical practitioner or pharmacy rather than their optometrist.
Confidence in prescribing for different conditions
The vast majority of therapeutically endorsed optometrists were confident to independently manage patients with allergic conjunctivitis, dry eye, episcleritis, infective conjunctivitis/blepharitis, meibomianitis and superficial inflammation. Less confidence and increasing reliance on ophthalmology was reported for patients with glaucoma, microbial keratitis, uveitis and to a lesser extent viral keratitis. These conditions might be considered more serious because of their potential for irreversible loss of vision.
Patients with glaucoma
Although a number of therapeutically endorsed optometrists considered that they could manage some glaucoma cases, OBA guidelines mandate that they must offer the patient a referral to an ophthalmologist within four months of commencing treatment for chronic glaucoma. 
Referrals to general medical practitioners and nonophthalmological specialists
Almost half of the respondents reported occasionally referring patients to general medical practitioners recommending further referral. Although the infrequent referral of patients to general medical practitioners recommending further referral to non-ophthalmological specialists found in this study may suggest a reluctance to do this, it may also imply that there is seldom a need to do this, either because of low presentation rates of relevant conditions or that the cases where referral was needed could be managed by the general practitioner or an ophthalmologist. Optometrists are unable to refer patients to specialists other than ophthalmologists if the patient is to receive Medicare benefits at the specialist rate; however, there are a number of conditions that both endorsed and non-endorsed optometrists consider they would be able to refer directly to a specialist (pituitary tumour, suspected III nerve palsy and eyelid lesions). Currently, the process would be to refer these patients to an ophthalmologist, hospital or general practitioner for further management.
Confidence examining and managing different patient groups, including diabetes
Endorsed optometrists tended to be slightly more confident in examining and managing a range of patient presentations, although some variations with age were also evident, such as increased confidence to examine and manage patients requiring domiciliary care with increasing age of the optometrist. The most challenging categories of patients were patients requiring advanced contact lens fittings (for example, rigid gas-permeables, orthokeratology) and patients requiring vision therapy. Over 93.5 per cent of optometrists in all age groups were very or moderately confident to examine and manage post-surgical patients.
Management of patients with diabetes was fairly consistent for both endorsed and non-endorsed optometrists, although endorsed optometrists were more likely to recommend dilated ocular fundus examination to all patients with diabetes. Both groups were confident to refer in accordance with NHMRC guidelines. The number of optometrists in clinical practice in September 2015 was likely to be larger with the addition of new graduates and the likelihood that those who indicated that they were involved in research or teaching in the OBA workforce document completed at the time of registration renewal may also have been involved in clinical practice. The 587 optometrists responding to the survey represent approximately 13.9 per cent of the 4,229 self-reported clinicians in 2014.
In September 2015, there were 4,825 practising optometrist registrations with the OBA; 6 these data are not confined to optometrists in clinical practice but include optometrists in administration, research and education. The breakdown by age of OBA registrants was 20 per cent in their 20s, 27 per cent in their 30s, 25 per cent in their 40s, 20 per cent in their 50s, seven per cent in their 60s and one per cent aged 70 and over. 6 The proportions in the current study were 14, 21, 29, 23, 13 and two per cent for these age groups, respectively. In comparison to OBA September 2015 general registration data by age, there was a lower proportion of optometrists under the age of 39 and slightly higher proportions for those in older age groups in the respondents to this survey (AIHW data were not used in this comparison since they use different age ranges).
Data from the OBA indicated that there were 2,115 therapeutic endorsements in September 2015. This survey thus represents 12 per cent (254 of 2,115) of all therapeutic endorsements. 6 The survey can be considered fairly representative of the profession as it has representation in all age groups, is approximately 14 per cent of optometrists listed by the OBA as being in the workforce in Australia and comprises 12 per cent of those with therapeutic endorsement of their registration. Further there was representation from all practice locations, although with less representation in city and more in regional areas than in HWA data for 2014. 8, 11 Figures for the survey and HWA were 63 and 78 per cent, respectively for major cities, 26 and 16 per cent, respectively for regional centres, 10 and five per cent, respectively, for outer regional areas, and one per cent for remote areas. There were differences in data collection, with HWA figures based on assignment of postcodes provided by optometrists to the five different remoteness classifications, while in the Optometry Australia survey, optometrists were asked to self-assign their locations to four categories. In both cases, the greatest representation was for major cities with a decrease with increasing remoteness. It is not possible to make comparisons about practice type as data collected by HWA did not use the breakdown that Optometry Australia required.
CONCLUSION
Information from the survey will guide Optometry Australia in the design of continuing professional development programs and other resources for optometrists, such as Practice Notes and Clinical Guidelines. The data indicate that it may be worth attempting to liaise with government for optometrists to be able to refer specific conditions directly to nonophthalmologic specialists and for these patients to be able to access specialist Medicare rebates.
